← Eichor
Study identifier: NCT06109337 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder

Condition: ADHD · Immune System · Clinical Syndrome  ·  Sponsor: First Affiliated Hospital of Zhejiang University

PhaseN/A
Planned participants100
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersYes

About this study

The goal of this observational study is to learn about The immune cell landscape of peripheral blood mononuclear cells in children with ADHD compared to typically developing controls. The main question it aims to answer are: 1.Testing the differences in immune cell subpopulations, protein expression and signaling pathways and cell subsets between two groups 2. Exploring the correlations between immune function in PBMC and resting-state brain functional networks in children with ADHD. Participants will be taken peripheral blood about 5 ml , cognitive assessment including Intelligence testing, Stroop color-word test and Trail making test, clinical interview and brain structural and functional MRI.

This description comes directly from the study's public registry record.

Talk to the study team

Hu Shaohua, doctor  ·  13957162903  ·  dorhushaohua@zju.edu.cn

Fu Guanghui, doctor  ·  18801170914  ·  fuguanghui@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Fu GuanghuiHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06109337